# A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity

> **NCT07717814** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 154 (actual)

## Conditions studied

- Overweight and Obesity

## Interventions

- **DRUG:** AMG 133 (frozen liquid)
- **DRUG:** AMG 133 (liquid)

## Key facts

- **NCT ID:** NCT07717814
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-26
- **Primary completion:** 2025-05-22
- **Final completion:** 2025-06-02
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07717814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07717814, "A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07717814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*